122 related articles for article (PubMed ID: 18491381)
1. Constitutive and dynamic phosphorylation and acetylation sites on NUCKS, a hypermodified nuclear protein, studied by quantitative proteomics.
Wiśniewski JR; Zougman A; Krüger S; Ziółkowski P; Pudełko M; Bebenek M; Mann M
Proteins; 2008 Nov; 73(3):710-8. PubMed ID: 18491381
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical and proteomic evaluation of nuclear ubiquitous casein and cyclin-dependent kinases substrate in invasive ductal carcinoma of the breast.
Ziółkowski P; Gamian E; Osiecka B; Zougman A; Wiśniewski JR
J Biomed Biotechnol; 2009; 2009():919645. PubMed ID: 20069058
[TBL] [Abstract][Full Text] [Related]
3. Identification of kinases phosphorylating 13 sites in the nuclear, DNA-binding protein NUCKS.
Grundt K; Thiede B; Østvold AC
Biochim Biophys Acta Proteins Proteom; 2017 Mar; 1865(3):359-369. PubMed ID: 28011258
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of two putative nuclear localization signals (NLS) in the DNA-binding protein NUCKS.
Grundt K; Haga IV; Huitfeldt HS; Ostvold AC
Biochim Biophys Acta; 2007 Sep; 1773(9):1398-406. PubMed ID: 17604136
[TBL] [Abstract][Full Text] [Related]
5. The comparison of nuclear ubiquitous casein and cyclin-dependent kinases substrate (NUCKS) with Ki67 proliferation marker expression in common skin tumors.
Zduniak K; Agrawal S; Symonowicz K; Jurczyszyn K; Ziółkowski P
Pol J Pathol; 2014 Mar; 65(1):48-54. PubMed ID: 25119009
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning of a mammalian nuclear phosphoprotein NUCKS, which serves as a substrate for Cdk1 in vivo.
Ostvold AC; Norum JH; Mathiesen S; Wanvik B; Sefland I; Grundt K
Eur J Biochem; 2001 Apr; 268(8):2430-40. PubMed ID: 11298763
[TBL] [Abstract][Full Text] [Related]
7. Dynamic expression of the vertebrate-specific protein Nucks during rodent embryonic development.
Drosos Y; Kouloukoussa M; Ostvold AC; Havaki S; Katsantoni E; Marinos E; Aleporou-Marinou V
Gene Expr Patterns; 2014 Jan; 14(1):19-29. PubMed ID: 24140890
[TBL] [Abstract][Full Text] [Related]
8. A putative DNA-binding domain in the NUCKS protein.
Grundt K; Skjeldal L; Anthonsen HW; Skauge T; Huitfeldt HS; Østvold AC
Arch Biochem Biophys; 2002 Nov; 407(2):168-75. PubMed ID: 12413487
[TBL] [Abstract][Full Text] [Related]
9. Analysis of dynamic changes in post-translational modifications of human histones during cell cycle by mass spectrometry.
Bonenfant D; Towbin H; Coulot M; Schindler P; Mueller DR; van Oostrum J
Mol Cell Proteomics; 2007 Nov; 6(11):1917-32. PubMed ID: 17644761
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of the NUCKS gene on human chromosome 1q32.1 and the presence of a homologous gene in different species.
Grundt K; Haga IV; Aleporou-Marinou V; Drosos Y; Wanvik B; Østvold AC
Biochem Biophys Res Commun; 2004 Oct; 323(3):796-801. PubMed ID: 15381070
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical studies on the nuclear ubiquitous casein and cyclin-dependent kinases substrate following 5-aminolevulinicacid-mediated photodynamic therapy on MCF-7 cells.
Hotowy K; Woźniak M; Duś K; Czapińska E; Osiecka B; Krzystek-Korpacka M; Bronowicz A; Wiśniewski J; Gamian A; Terlecki G; Ziółkowski P
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):518-25. PubMed ID: 24284105
[TBL] [Abstract][Full Text] [Related]
12. Effect of NUCKS-1 overexpression on cytokine profiling in obese women with breast cancer.
Soliman NA; Zineldeen DH; El-Khadrawy OH
Asian Pac J Cancer Prev; 2014; 15(2):837-45. PubMed ID: 24568505
[TBL] [Abstract][Full Text] [Related]
13. NUCKS: a potential biomarker in cancer and metabolic disease.
Qiu B; Han W; Tergaonkar V
Clin Sci (Lond); 2015 May; 128(10):715-21. PubMed ID: 25760963
[TBL] [Abstract][Full Text] [Related]
14. Nepsilon-formylation of lysine is a widespread post-translational modification of nuclear proteins occurring at residues involved in regulation of chromatin function.
Wisniewski JR; Zougman A; Mann M
Nucleic Acids Res; 2008 Feb; 36(2):570-7. PubMed ID: 18056081
[TBL] [Abstract][Full Text] [Related]
15. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey.
Kim SC; Sprung R; Chen Y; Xu Y; Ball H; Pei J; Cheng T; Kho Y; Xiao H; Xiao L; Grishin NV; White M; Yang XJ; Zhao Y
Mol Cell; 2006 Aug; 23(4):607-18. PubMed ID: 16916647
[TBL] [Abstract][Full Text] [Related]
16. Signaling to p53: breaking the posttranslational modification code.
Appella E; Anderson CW
Pathol Biol (Paris); 2000 Apr; 48(3):227-45. PubMed ID: 10858956
[TBL] [Abstract][Full Text] [Related]
17. Lysine acetylation: codified crosstalk with other posttranslational modifications.
Yang XJ; Seto E
Mol Cell; 2008 Aug; 31(4):449-461. PubMed ID: 18722172
[TBL] [Abstract][Full Text] [Related]
18. Large-scale characterization of HeLa cell nuclear phosphoproteins.
Beausoleil SA; Jedrychowski M; Schwartz D; Elias JE; Villén J; Li J; Cohn MA; Cantley LC; Gygi SP
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12130-5. PubMed ID: 15302935
[TBL] [Abstract][Full Text] [Related]
19. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
Cuomo A; Moretti S; Minucci S; Bonaldi T
Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
[TBL] [Abstract][Full Text] [Related]
20. Nuclear phosphoproteome analysis of 3T3-L1 preadipocyte differentiation reveals system-wide phosphorylation of transcriptional regulators.
Rabiee A; Schwämmle V; Sidoli S; Dai J; Rogowska-Wrzesinska A; Mandrup S; Jensen ON
Proteomics; 2017 Mar; 17(6):. PubMed ID: 27717184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
